Author:
Hanumegowda Umesh M,Regueiro-Ren Alicia
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Willard J (2008) FDA Phospholipidosis Working Group, Preliminary results and developing opinions [abstract]. Society of Toxicological Pathology, 27th annual symposium, San Francisco, CA
2. Sun H, Xia M, Shahane SA, Jadhav A, Austin CP, Huang R (2013) Are hERG channel blockers also phospholipidosis inducers? Bioorg Med Chem Lett 23:4587–4590
3. Kodavanti UP, Mehendale HM (1990) Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 42:327–354
4. Laurent G, Kishore BK, Tulkens PM (1990) Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 40:2383–2392
5. Van Bambeke F, Montenez JP, Piret J, Tulkens PM, Courtoy PJ, Mingeot-Leclercq MP (1996) Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. Eur J Pharmacol 314:203–214
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献